Pooled Analysis of Tanezumab Efficacy and Safety with Subgroup Analyses of Phase III Clinical Trials in Patients with Osteoarthritis Pain of the Knee or Hip [Corrigendum]
Tive L, Bello AE, Radin D, et al. J Pain Res. 2019;12:975 —995.
The authors have advised there is an error in the middle panels of Figure 6 on page 985. Both panels read “Patients with severe OA” the panel on the right should read “Patients with less severe OA”.
The correct Figure 6 is shown below.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]